DE3650190D1 - Neues Verfahren zur Isolierung von Castanospermin. - Google Patents

Neues Verfahren zur Isolierung von Castanospermin.

Info

Publication number
DE3650190D1
DE3650190D1 DE3650190T DE3650190T DE3650190D1 DE 3650190 D1 DE3650190 D1 DE 3650190D1 DE 3650190 T DE3650190 T DE 3650190T DE 3650190 T DE3650190 T DE 3650190T DE 3650190 D1 DE3650190 D1 DE 3650190D1
Authority
DE
Germany
Prior art keywords
castanospermine
isolating
new process
tetrc
enydroxyindolizidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3650190T
Other languages
English (en)
Other versions
DE3650190T2 (de
Inventor
Paul S Liu
Barry L Rhinehart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE3650190D1 publication Critical patent/DE3650190D1/de
Application granted granted Critical
Publication of DE3650190T2 publication Critical patent/DE3650190T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3650190T 1985-05-24 1986-05-21 Neues Verfahren zur Isolierung von Castanospermin. Expired - Fee Related DE3650190T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73812785A 1985-05-24 1985-05-24

Publications (2)

Publication Number Publication Date
DE3650190D1 true DE3650190D1 (de) 1995-02-09
DE3650190T2 DE3650190T2 (de) 1995-05-11

Family

ID=24966697

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3650190T Expired - Fee Related DE3650190T2 (de) 1985-05-24 1986-05-21 Neues Verfahren zur Isolierung von Castanospermin.
DE86106863T Expired - Fee Related DE3688807T2 (de) 1985-05-24 1986-05-21 Isolierung von Castanospermin und dessen Verwendung als antidiabetisches Heilmittel.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE86106863T Expired - Fee Related DE3688807T2 (de) 1985-05-24 1986-05-21 Isolierung von Castanospermin und dessen Verwendung als antidiabetisches Heilmittel.

Country Status (5)

Country Link
EP (2) EP0202661B1 (de)
JP (2) JPH0729923B2 (de)
AT (2) ATE116321T1 (de)
CA (1) CA1327970C (de)
DE (2) DE3650190T2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
GB8827701D0 (en) * 1987-12-09 1988-12-29 Nippon Shinyaku Co Ltd Thrombolytic &c compositions
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent
JPH04500959A (ja) * 1988-08-10 1992-02-20 ジ オーストラリアン ナショナル ユニバーシティー 抗炎症剤および免疫抑制剤としてのカスタノスペルミンの使用
GB8924292D0 (en) * 1989-10-27 1989-12-13 Novalal Ltd The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase
US5844102A (en) * 1994-07-07 1998-12-01 University Of Maryland Baltimore County Glycohydrolase inhibitors, their preparation and use thereof
US10328061B2 (en) 2016-05-02 2019-06-25 Florida State University Research Foundation, Inc. Treatment of Zika virus infections using alpha-glucosidase inhibitors
US11518762B2 (en) * 2020-06-04 2022-12-06 Florida State University Research Foundation, Inc. Large scale purification of castanospermine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法

Also Published As

Publication number Publication date
EP0522599A1 (de) 1993-01-13
JP2528083B2 (ja) 1996-08-28
DE3688807T2 (de) 1994-02-10
CA1327970C (en) 1994-03-22
DE3650190T2 (de) 1995-05-11
EP0522599B1 (de) 1994-12-28
EP0202661B1 (de) 1993-08-04
DE3688807D1 (de) 1993-09-09
JPH0729923B2 (ja) 1995-04-05
EP0202661A2 (de) 1986-11-26
ATE92318T1 (de) 1993-08-15
JPS61271220A (ja) 1986-12-01
ATE116321T1 (de) 1995-01-15
EP0202661A3 (en) 1990-07-25
JPH07252151A (ja) 1995-10-03

Similar Documents

Publication Publication Date Title
ATA64985A (de) Verfahren zur herstellung von neuen 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivaten
ATA257986A (de) Verfahren zur herstellung von neuen azetidinderivaten
DE3650547D1 (de) Verfahren zur Herstellung von Halbleiterlasern
AT385755B (de) Verfahren zur herstellung von neuen pyrensulfonsaeurederivaten
DE3672942D1 (de) Verfahren zur herstellung von tetrafluorbenzoesaeure.
DE3650190D1 (de) Neues Verfahren zur Isolierung von Castanospermin.
ATE71104T1 (de) Neues verfahren zur herstellung von sphingosinderivaten.
DK318786D0 (da) Fremgangsmaade til rensning af l-ascorbinsyre
AT388556B (de) Stereogesteuertes verfahren zur herstellung von neuen penem-verbindungen
DE3671742D1 (de) Verfahren zur herstellung von dialkalisalzen der naphthalin-2,6-dicarbonsaeure.
DE3677838D1 (de) Verfahren zur herstellung von alkylestern von 3,4-epoxybuttersaeure.
ATA149286A (de) Verfahren zur herstellung von neuen chinolinderivaten
DE3688302D1 (de) Verfahren zur herstellung von 7-aca-derivaten.
DK307386D0 (da) Fremgangsmaade til rensning af l-ascorbinsyre
AT386824B (de) Verfahren zur herstellung von n-sulfanyl-3(2-guanidinothazol-4-yl-methylthio)-propionamid n
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
ATA313686A (de) Verfahren zur herstellung von neuen carbapenemderivaten
DD252605A1 (de) Verfahren zur herstellung von carbapenem-antibiotika
AT386407B (de) Verfahren zur herstellung von neuen n-sulfamyl -3-halogenpropionamidinen
PT82393A (de) Verfahren zur herstellung von neuen benzoesaeurederivaten
DE3775774D1 (de) Verfahren zur herstellung von alkyl-tert-butylaethern.
DE3672926D1 (de) Verfahren zur herstellung von 6-amino-penicillansaeure-1,1-dioxyd durch oxydation von 6-amino-penicillansaeure.
AT381232B (de) Verfahren zur herstellung stabiler fluessiger loesungen von ergolinderivaten
AT374795B (de) Verfahren zur herstellung von neuen derivaten der pyrrol-2-essigsaeure
AT383810B (de) Verfahren zur herstellung von cephalosporinderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee